Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Brain-penetrant ALK inhibitor NUV-655 active against treatment-resistant mutations

April 22, 2021

Enrollment begins in phase I/II study of etrumadenant in metastatic colorectal cancer

April 22, 2021

Initiation of NOBLE Registry for Telix's TLX599-CDx SPECT in prostate cancer

April 21, 2021

New molecular imaging and therapy trials open at Hoag

April 21, 2021

Medshine Discovery patent describes LSD1 inhibitors

April 21, 2021

New GTPase KRAS mutant inhibitors presented by BeiGene

April 21, 2021

Fujifilm divulges FGFR inhibitors

April 21, 2021

Sumitomo Dainippon Pharma patents new compounds for cancer

April 21, 2021

Discovery and preclinical characterization of novel KRAS G12C inhibitor, LY-3537982

April 21, 2021

FDA allows Vincerx Pharma to conduct phase Ib study of VIP-152 in CLL and Richter syndrome

April 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 30, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026